Related Experiment Video
Updated: Jun 3, 2026

Nanopodia - Thin, Fragile Membrane Projections with Roles in Cell Movement and Intercellular Interactions
Published on: April 3, 2014
Tetraspanin CD9 in cell migration
Dale Powner1, Petra M Kopp, Susan J Monkley
1School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Abstract:
Tetraspanin CD9 is associated with integrin adhesion receptors and it was reported that CD9 regulates integrin-dependent cell migration and invasion. Pro- and anti-migratory effects of CD9 have been linked to adhesion-dependent signalling pathways, including phosphorylation of FAK (focal adhesion kinase) and activation of phosphoinositide 3-kinase, p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase). In the present paper, we describe a novel mechanism whereby CD9 specifically controls localization of talin1, one of the critical regulators of integrin activation, to focal adhesions: CD9-deficiency leads to impaired localization of talin1 to focal adhesions and correlates with increased motility of breast cancer cells.
Insights
Tetraspanin CD9 deficiency impairs talin1 localization to focal adhesions, a key regulator of integrin activation. This leads to increased breast cancer cell motility, revealing a novel CD9-dependent mechanism in cell migration.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Tetraspanin CD9 interacts with integrin adhesion receptors, influencing cell migration and invasion.
- CD9's role in cell migration is linked to signaling pathways like FAK, PI3K, p38 MAPK, and JNK.
- Integrin activation is crucial for cell adhesion and migration, regulated by proteins like talin1.
Purpose of the Study:
- To elucidate a novel mechanism by which CD9 regulates integrin-dependent cell migration.
- To investigate the specific role of CD9 in the localization of talin1 to focal adhesions.
- To determine the impact of CD9 deficiency on breast cancer cell motility.
Main Methods:
- Analysis of CD9-deficient cells.
- Immunofluorescence microscopy to assess talin1 localization at focal adhesions.
- Cell motility assays to quantify breast cancer cell migration.
Main Results:
- CD9 deficiency results in impaired localization of talin1 to focal adhesions.
- Loss of CD9 correlates with increased motility of breast cancer cells.
- This suggests CD9 plays a critical role in regulating talin1 dynamics at focal adhesions.
Conclusions:
- CD9 specifically controls the localization of talin1 to focal adhesions.
- CD9-deficiency disrupts normal talin1 localization, leading to enhanced breast cancer cell migration.
- This finding uncovers a new mechanism by which CD9 influences cell adhesion and motility.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Cytoskeletal Coordination in Cell Migration
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction. It is...
Intracellular Signaling Affects Focal Adhesions
Some...

